tradingkey.logo

DSS Inc

DSS
0.918USD
-0.042-4.37%
收盘 12/31, 16:00美东报价延迟15分钟
8.35M总市值
亏损市盈率 TTM

DSS Inc

0.918
-0.042-4.37%

关于 DSS Inc 公司

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

DSS Inc简介

公司代码DSS
公司名称DSS Inc
上市日期Oct 27, 1993
CEOGrady (Jason)
员工数量100
证券类型Ordinary Share
年结日Oct 27
公司地址275 Wiregrass Pkwy
城市WEST HENRIETTA
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编14586
电话15852321500
网址https://www.dssworld.com/
公司代码DSS
上市日期Oct 27, 1993
CEOGrady (Jason)

DSS Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
Packaging Printing and Fabrication
4.15M
78.52%
Commercial and Security Printing
122.00K
2.31%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
其他
32.76%
持股股东
持股股东
占比
Alset Ehome International Inc
40.14%
Chan (Heng Fai Ambrose)
22.62%
Global Biomedical Pte Ltd.
3.43%
The Vanguard Group, Inc.
0.71%
Renaissance Technologies LLC
0.35%
其他
32.76%
股东类型
持股股东
占比
Corporation
43.57%
Individual Investor
22.62%
Investment Advisor
0.95%
Hedge Fund
0.37%
Investment Advisor/Hedge Fund
0.25%
Research Firm
0.03%
其他
32.21%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
35
145.92K
1.60%
-49.38K
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
Wells Fargo Advisors
157.00
0%
+155.00
+7750.00%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
公告日期
类型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1

常见问题

DSS Inc的前五大股东是谁?

DSS Inc 的前五大股东如下:
Alset Ehome International Inc持有股份:3.65M,占总股份比例:40.14%。
Chan (Heng Fai Ambrose)持有股份:2.06M,占总股份比例:22.62%。
Global Biomedical Pte Ltd.持有股份:311.63K,占总股份比例:3.43%。
The Vanguard Group, Inc.持有股份:64.83K,占总股份比例:0.71%。
Renaissance Technologies LLC持有股份:31.45K,占总股份比例:0.35%。

DSS Inc的前三大股东类型是什么?

DSS Inc 的前三大股东类型分别是:
Alset Ehome International Inc
Chan (Heng Fai Ambrose)
Global Biomedical Pte Ltd.

有多少机构持有DSS Inc(DSS)的股份?

截至2025Q4,共有35家机构持有DSS Inc的股份,合计持有的股份价值约为145.92K,占公司总股份的1.60%。与2025Q3相比,机构持股有所增加,增幅为-0.54%。

哪个业务部门对DSS Inc的收入贡献最大?

在FY2025Q2,Packaging Printing and Fabrication业务部门对DSS Inc的收入贡献最大,创收4.15M,占总收入的78.52%。
KeyAI